{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:52:16Z","timestamp":1792821136768,"version":"4.5.0"},"reference-count":180,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T00:00:00Z","timestamp":1494374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jare.2017.04.008","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T10:59:49Z","timestamp":1494500389000},"page":"495-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":480,"title":["Gout: An old disease in new perspective \u2013 A review"],"prefix":"10.1016","volume":"8","author":[{"given":"Gaafar","family":"Ragab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Elshahaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10055","key":"10.1016\/j.jare.2017.04.008_b0005","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Gout Lancet"},{"issue":"7","key":"10.1016\/j.jare.2017.04.008_b0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199602153340707","article-title":"The management of gout","volume":"334","author":"Emmerson","year":"1996","journal-title":"New Engl J Med"},{"issue":"8","key":"10.1016\/j.jare.2017.04.008_b0015","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/ard.2006.060368","article-title":"Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout","volume":"66","author":"Pascual","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/RHU.0000000000000091","article-title":"Challenges faced by patients in gout treatment: a qualitative study","volume":"20","author":"Singh","year":"2014","journal-title":"J Clin Rheumatol: Practical Rep Rheum Musculoskelet Dis"},{"issue":"11","key":"10.1016\/j.jare.2017.04.008_b0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jare.2017.04.008_b0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/0003-4819-54-3-452","article-title":"Identification of urate crystals in gouty synovial fluid","volume":"54","author":"McCarty","year":"1961","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jare.2017.04.008_b0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu Rev Physiol"},{"issue":"12","key":"10.1016\/j.jare.2017.04.008_b0040","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/ndt\/gfu256","article-title":"A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population","volume":"29","author":"Kamei","year":"2014","journal-title":"Nephrol, Dialysis, Transplant: official publication of the European Dialysis and Transplant Association \u2013 European Renal Association"},{"key":"10.1016\/j.jare.2017.04.008_b0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1172-2-48","article-title":"Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome","volume":"2","author":"Torres","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/BOR.0b013e328040c00b","article-title":"Genetics and experimental models of crystal-induced arthritis. Lessons learned from mice and men: is it crystal clear?","volume":"19","author":"Reginato","year":"2007","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"10.1016\/j.jare.2017.04.008_b0055","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1080\/15257770.2011.596498","article-title":"Effect of urine pH on uric acid excretion by manipulating food materials","volume":"30","author":"Kanbara","year":"2011","journal-title":"Nucleosides, Nucleotides Nucleic Acids"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/1756-185X.12622","article-title":"The association of vitamin C, alcohol, coffee, tea, milk and yogurt with uric acid and gout","volume":"18","author":"Towiwat","year":"2015","journal-title":"Int J Rheum Dis"},{"issue":"Suppl 4","key":"10.1016\/j.jare.2017.04.008_b0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/bjc.1998.432","article-title":"Advances in the management of malignancy-associated hyperuricaemia","volume":"77","author":"Mahmoud","year":"1998","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.jare.2017.04.008_b0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/ard.57.9.509","article-title":"Hyperlipidaemia in hyperuricaemia and gout","volume":"57","author":"Emmerson","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0075","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1536\/jhj.44.527","article-title":"Leptin might be a regulator of serum uric acid concentrations in humans","volume":"44","author":"Bedir","year":"2003","journal-title":"Jpn Heart J"},{"issue":"7","key":"10.1016\/j.jare.2017.04.008_b0080","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/ard.59.7.539","article-title":"Beneficial effects of weight loss associated with moderate calorie\/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study","volume":"59","author":"Dessein","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2017.04.008_b0085","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nature Commun"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10157-005-0368-5","article-title":"Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease","volume":"9","author":"Enomoto","year":"2005","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0095","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.ackd.2012.07.009","article-title":"Renal transport of uric acid: evolving concepts and uncertainties","volume":"19","author":"Bobulescu","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0100","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ki.2012.449","article-title":"Common genetic variants of the human uromodulin gene regulate transcription and predict plasma uric acid levels","volume":"83","author":"Han","year":"2013","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.jare.2017.04.008_b0105","doi-asserted-by":"crossref","first-page":"e009360","DOI":"10.1136\/bmjopen-2015-009360","article-title":"Discovery of URAT1 SNPs and association between serum uric acid levels and URAT1","volume":"5","author":"Cho","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.jare.2017.04.008_b0110","doi-asserted-by":"crossref","first-page":"34995","DOI":"10.1038\/srep34995","article-title":"Mechanism of high affinity inhibition of the human urate transporter URAT1","volume":"6","author":"Tan","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2014-205877","article-title":"Twenty-eight loci that influence serum urate levels: analysis of association with gout","volume":"75","author":"Phipps-Green","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0120","doi-asserted-by":"crossref","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","article-title":"Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations","volume":"5","author":"Kolz","year":"2009","journal-title":"PLoS Genet"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0125","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/1529-0131(200005)43:5<1145::AID-ANR25>3.0.CO;2-T","volume":"43","author":"Liu","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/RHU.0b013e31827d8790","article-title":"Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis","volume":"19","author":"Cronstein","year":"2013","journal-title":"J Clin Rheumatol: Practical Rep Rheumat Musculoskelet Dis"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4081\/reumatismo.2011.230","article-title":"The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis)","volume":"63","author":"Busso","year":"2012","journal-title":"Reumatismo"},{"issue":"9 Pt 1","key":"10.1016\/j.jare.2017.04.008_b0140","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.lpm.2011.03.016","article-title":"Mechanisms of gout inflammation","volume":"40","author":"Ea","year":"2011","journal-title":"Presse Med"},{"issue":"10","key":"10.1016\/j.jare.2017.04.008_b0145","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0150","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s11926-013-0392-5","article-title":"Mechanisms of spontaneous resolution of acute gouty inflammation","volume":"16","author":"Steiger","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4081\/reumatismo.2011.238","article-title":"Clinical features of gout","volume":"63","author":"Grassi","year":"2012","journal-title":"Reumatismo"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10067-011-1877-0","article-title":"An update on the pathology and clinical management of gouty arthritis","volume":"31","author":"Gonzalez","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.jare.2017.04.008_b0165","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1136\/ard.2010.128454","article-title":"The pathogenesis of bone erosions in gouty arthritis","volume":"69","author":"Schlesinger","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0170","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1053\/j.ajkd.2009.09.008","article-title":"The validity of fractional excretion of uric acid in the diagnosis of acute kidney injury due to decreased kidney perfusion","volume":"54","author":"Kosmadakis","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/2040622312462056","article-title":"Latest evidence on gout management: what the clinician needs to know","volume":"3","author":"Burns","year":"2012","journal-title":"Therap Adv Chronic Dis"},{"issue":"8","key":"10.1016\/j.jare.2017.04.008_b0180","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2215\/CJN.11451210","article-title":"A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function","volume":"6","author":"Kanbay","year":"2011","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"issue":"7","key":"10.1016\/j.jare.2017.04.008_b0185","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/rheumatology\/kep069","article-title":"Allopurinol and mortality in hyperuricaemic patients","volume":"48","author":"Luk","year":"2009","journal-title":"Rheumatol (Oxford, England)"},{"issue":"10","key":"10.1016\/j.jare.2017.04.008_b0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11926-016-0613-9","article-title":"Gout and osteoarthritis: associations, pathophysiology, and therapeutic implications","volume":"18","author":"Yokose","year":"2016","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0195","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11926-010-0094-1","article-title":"Uric acid and hypertension: cause or effect?","volume":"12","author":"Mazzali","year":"2010","journal-title":"Curr Rheumatol Rep"},{"issue":"27","key":"10.1016\/j.jare.2017.04.008_b0200","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.2174\/1381612811319270016","article-title":"Uric acid and diabetes: Is there a link?","volume":"19","author":"Katsiki","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1757-1146-4-13","article-title":"Revisiting the pathogenesis of podagra: why does gout target the foot?","volume":"4","author":"Roddy","year":"2011","journal-title":"J Foot Ankle Res"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0210","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/ard.38.4.326","article-title":"Acute gouty bursitis: report of 15 cases","volume":"38","author":"Canoso","year":"1979","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.rdc.2014.01.003","article-title":"Clinical manifestations and diagnosis of gout","volume":"40","author":"Perez-Ruiz","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"issue":"10","key":"10.1016\/j.jare.2017.04.008_b0220","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","article-title":"Synovial fluid analysis for diagnosis of intercritical gout","volume":"131","author":"Pascual","year":"1999","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11926-014-0492-x","article-title":"The gouty tophus: a review","volume":"17","author":"Chhana","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/RHU.0b013e3181945b79","article-title":"Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis","volume":"15","author":"Malik","year":"2009","journal-title":"J Clin Rheumatol: Practical Rep Rheum Musculoskelet Dis"},{"issue":"10","key":"10.1016\/j.jare.2017.04.008_b0235","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: diagnosis. report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0240","first-page":"989","article-title":"Coexistence of chronic tophaceous gout and rheumatoid arthritis","volume":"8","author":"Atdjian","year":"1981","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.jare.2017.04.008_b0245","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3949\/ccjm.69.8.594","article-title":"Asymptomatic hyperuricemia: to treat or not to treat","volume":"69","author":"Dincer","year":"2002","journal-title":"Clevel Clin J Med"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0250","first-page":"942","article-title":"Acute gout attack with normal serum uric acid levels","volume":"118","author":"Badulescu","year":"2014","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"issue":"7553","key":"10.1016\/j.jare.2017.04.008_b0255","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.332.7553.1315","article-title":"Diagnosis and management of gout","volume":"332","author":"Underwood","year":"2006","journal-title":"BMJ (Clin Res Ed)"},{"issue":"12","key":"10.1016\/j.jare.2017.04.008_b0260","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.48.12.983","article-title":"The ordinary light microscope: an appropriate tool for provisional detection and identification of crystals in synovial fluid","volume":"48","author":"Pascual","year":"1989","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.jare.2017.04.008_b0265","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jama.1968.03140070064014","article-title":"Compensated polarized light microscopy. Identification of crystals in synovial fluids from gout and pseudogout","volume":"203","author":"Phelps","year":"1968","journal-title":"JAMA"},{"key":"10.1016\/j.jare.2017.04.008_b0270","series-title":"Urinalysis & body fluids","author":"Strasinger","year":"2008"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0275","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/ajkd.2002.33911","article-title":"The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988\u20131994","volume":"40","author":"Kramer","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jare.2017.04.008_b0280","unstructured":"Fernandes EA, Bergamaschi SB, Rodrigues TC, Dias GC, Malmann R, Ramos GM, et al. Relevant aspects of imaging in the diagnosis and management of gout. Revista brasileira de reumatologia. 2016."},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0285","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00330-007-0802-z","article-title":"Diagnostic imaging of gout: comparison of high-resolution US versus conventional X-ray","volume":"18","author":"Rettenbacher","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jare.2017.04.008_b0290","first-page":"94","article-title":"Gout and ultrasound: the disease of kings and the queen of imaging","volume":"1","author":"Namas","year":"2014","journal-title":"Gout Hyperuricaemia"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0295","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2214\/ajr.134.4.781","article-title":"A radiologic reevaluation of gout: a study of 2,000 patients","volume":"134","author":"Bloch","year":"1980","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jare.2017.04.008_b0300","unstructured":"Malghem J, Vande Berg B, Lecouvet F. Goutte d\u2019hier et d\u2019aujourd\u2019hui. Imagerie de l\u2019appareil musculo-squlettique: Textes choisis. Montpellier (France): Sauramps Medical; 2011. p. 35\u201344."},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0305","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.rdc.2016.07.005","article-title":"Imaging in gout and other crystal-related arthropathies","volume":"42","author":"Omoumi","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0310","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/91.4.755","article-title":"The overhanging margin of bone: a roentgenologic manifestation of gout","volume":"91","author":"Martel","year":"1968","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2003-43227","article-title":"Advanced imaging of gout","volume":"7","author":"Gentili","year":"2003","journal-title":"Semin Musculoskelet Radiol"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0320","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.rdc.2006.04.001","article-title":"Imaging features of crystal-induced arthropathy","volume":"32","author":"Choi","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11926-996-0030-6","article-title":"The advanced imaging of gouty tophi","volume":"8","author":"Gentili","year":"2006","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0330","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.semarthrit.2015.09.008","article-title":"Imaging as a potential outcome measure in gout studies: A systematic literature review","volume":"45","author":"Durcan","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0335","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.22891","article-title":"Validation of a radiographic damage index in chronic gout","volume":"57","author":"Dalbeth","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jare.2017.04.008_b0340","series-title":"Musculoskeletal ultrasonography in rheumatic diseases","first-page":"137","article-title":"Crystal-induced arthritis","author":"Nestorova","year":"2015"},{"key":"10.1016\/j.jare.2017.04.008_b0345","series-title":"Essential applications of musculoskeletal ultrasound in rheumatology","first-page":"187","article-title":"Chapter 16 - crystal-associated synovitis A2 \u2013 Wakefield, Richard J","author":"Grassi","year":"2010"},{"issue":"Suppl 7","key":"10.1016\/j.jare.2017.04.008_b0350","doi-asserted-by":"crossref","first-page":"vii18","DOI":"10.1093\/rheumatology\/kes332","article-title":"Tips and tricks to recognize microcrystalline arthritis","volume":"51","author":"Filippucci","year":"2012","journal-title":"Rheumatol (Oxford, England)"},{"issue":"Suppl 2","key":"10.1016\/j.jare.2017.04.008_b0355","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/annrheumdis-2014-eular.5580","article-title":"Defining elementary ultrasound lesions in gout. Preliminary results of Delphi consensus and web-exercise reliability","volume":"73","author":"Gutierrez","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.jare.2017.04.008_b0360","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2006.062802","article-title":"High-resolution ultrasonography of the first metatarsal phalangeal joint in gout: a controlled study","volume":"66","author":"Wright","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0365","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.joca.2008.06.003","article-title":"Hyaline cartilage involvement in patients with gout and calcium pyrophosphate deposition disease. An ultrasound study","volume":"17","author":"Filippucci","year":"2009","journal-title":"Osteoarthr Cartilage"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0370","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00296-009-1002-8","article-title":"Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved","volume":"30","author":"Thiele","year":"2010","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.jare.2017.04.008_b0375","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/rheumatology\/kem058","article-title":"Diagnosis of gout by ultrasound","volume":"46","author":"Thiele","year":"2007","journal-title":"Rheumatol (Oxford, England)"},{"issue":"8","key":"10.1016\/j.jare.2017.04.008_b0380","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2013-203487","article-title":"Ultrasound-detected musculoskeletal urate crystal deposition: which joints and what findings should be assessed for diagnosing gout?","volume":"73","author":"Naredo","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0385","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/rheumatology\/kes395","article-title":"Occurrence of tendon pathologies in metabolic disorders","volume":"52","author":"Abate","year":"2013","journal-title":"Rheumatol (Oxford, England)"},{"issue":"8","key":"10.1016\/j.jare.2017.04.008_b0390","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/ard.2008.094201","article-title":"Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography","volume":"68","author":"Dalbeth","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0395","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/ar3489","article-title":"Imaging in gout\u2013what can we learn from MRI, CT, DECT and US?","volume":"13","author":"McQueen","year":"2011","journal-title":"Arthritis Res Therapy"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0400","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/ard.61.1.52","article-title":"Imaging of tophaceous gout: computed tomography provides specific images compared with magnetic resonance imaging and ultrasonography","volume":"61","author":"Gerster","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0405","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/art.22612","article-title":"Computed tomography measurement of tophus volume: Comparison with physical measurement","volume":"57","author":"Dalbeth","year":"2007","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0410","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.jare.2017.04.008_b0415","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/art.1780390820","article-title":"Computed tomography of the knee joint as an indicator of intraarticular tophi in gout","volume":"39","author":"Gerster","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0420","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0035-1569255","article-title":"Optimization of radiation dose and image quality in musculoskeletal CT: emphasis on iterative reconstruction techniques (Part 1)","volume":"19","author":"Omoumi","year":"2015","journal-title":"Semin Musculoskelet Radiol"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0425","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0035-1569254","article-title":"Optimization of radiation dose and image quality in musculoskeletal CT: emphasis on iterative reconstruction techniques (Part 2)","volume":"19","author":"Omoumi","year":"2015","journal-title":"Semin musculoskelet Radiol"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0430","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-0035-1569253","article-title":"Dual-Energy CT: basic principles, technical approaches, and applications in musculoskeletal imaging (Part 1)","volume":"19","author":"Omoumi","year":"2015","journal-title":"Semin Musculoskelet Radiol"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0435","first-page":"1376","article-title":"Invited commentary","volume":"31","author":"Nicolaou","year":"2011","journal-title":"Radio Graph"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0440","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00296-014-2979-1","article-title":"Systemic staging for urate crystal deposits with dual-energy CT and ultrasound in patients with suspected gout","volume":"34","author":"Huppertz","year":"2014","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0445","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/annrheumdis-2013-205095","article-title":"Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study","volume":"74","author":"Bongartz","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0450","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.semarthrit.2013.11.002","article-title":"Gout tophus detection-a comparison of dual-energy CT (DECT) and histology","volume":"43","author":"Melzer","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0455","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/annrheumdis-2012-202452","article-title":"DECT urate deposits: now you see them, now you don't","volume":"72","author":"McQueen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0460","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1148\/radiol.11102485","article-title":"Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation","volume":"261","author":"Glazebrook","year":"2011","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0465","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1759720X14542960","article-title":"Imaging in gout: A review of the recent developments","volume":"6","author":"Chowalloor","year":"2014","journal-title":"Therap Adv Musculoskelet Dis"},{"issue":"12","key":"10.1016\/j.jare.2017.04.008_b0470","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11926-015-0547-7","article-title":"Gout in the spine: imaging, diagnosis, and outcomes","volume":"17","author":"Toprover","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"10.1016\/j.jare.2017.04.008_b0475","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sc.2015.93","article-title":"Thoracic cord compression due to ligamentum flavum gouty tophus: a case report and literature review","volume":"53","author":"Zheng","year":"2015","journal-title":"Spinal Cord"},{"key":"10.1016\/j.jare.2017.04.008_b0480","first-page":"357826","article-title":"Gout initially mimicking rheumatoid arthritis and later cervical spine involvement","volume":"2014","author":"Nunes","year":"2014","journal-title":"Case Rep Rheumatol"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0485","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/197140091202500518","article-title":"Spinal gout: a great mimicker. A case report and literature review","volume":"25","author":"Ahmad","year":"2012","journal-title":"Neuroradiol J"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0490","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/WNL.0b013e3181b04cb1","article-title":"Lower back pain caused by tophaceous gout of the spine","volume":"73","author":"Nygaard","year":"2009","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jare.2017.04.008_b0495","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1053\/crad.2001.1001","article-title":"Tophaceous gout of the spine: MR imaging features","volume":"57","author":"Hsu","year":"2002","journal-title":"Clin Radiol"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0500","first-page":"13","article-title":"Spondyloarthritis: a gouty display","volume":"4","author":"Gongidi","year":"2010","journal-title":"J Radiol Case Rep"},{"issue":"9","key":"10.1016\/j.jare.2017.04.008_b0505","first-page":"724","article-title":"An analysis of abnormal magnetic resonance imaging of sacroiliac joints in patients misdiagnosed as spondyloarthritis","volume":"53","author":"Zhao","year":"2014","journal-title":"Zhonghua nei ke za zhi"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0510","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3349\/ymj.2009.50.2.257","article-title":"Carpal tunnel syndrome caused by space occupying lesions","volume":"50","author":"Kang","year":"2009","journal-title":"Yonsei Med J"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0515","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2214\/ajr.175.3.1750655","article-title":"Carpal tunnel syndrome caused by tophaceous gout: CT and MR imaging features in 20 patients","volume":"175","author":"Chen","year":"2000","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0520","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuchi.2013.03.003","article-title":"Eighteen cases of crowned dens syndrome: Presentation and diagnosis","volume":"59","author":"Godfrin-Valnet","year":"2013","journal-title":"Neurochirurgie"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0525","first-page":"15","article-title":"Spinal gout mimicking paraspinal abscess: A case report","volume":"4","author":"Udayakumar","year":"2010","journal-title":"J Radiol Case Rep"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0530","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00256-004-0827-1","article-title":"Intra-abdominal gout mimicking pelvic abscess","volume":"34","author":"Chen","year":"2005","journal-title":"Skeletal Radiol"},{"issue":"12","key":"10.1016\/j.jare.2017.04.008_b0535","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.3899\/jrheum.141164","article-title":"Imaging as an outcome measure in gout studies: report from the OMERACT gout working group","volume":"42","author":"Grainger","year":"2015","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0540","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.39799","article-title":"Review: gout: a roadmap to approaches for improving global outcomes","volume":"69","author":"Dalbeth","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.jare.2017.04.008_b0545","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","article-title":"Gout: why is this curable disease so seldom cured?","volume":"71","author":"Doherty","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.jare.2017.04.008_b0550","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.jare.2017.04.008_b0555","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0560","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.jare.2017.04.008_b0565","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/acr.22336","article-title":"Medication adherence in gout: a systematic review","volume":"66","author":"De Vera","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0570","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jare.2017.04.008_b0575","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.30389","article-title":"Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.jare.2017.04.008_b0580","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s40264-013-0055-5","article-title":"Characterization of statin-associated myopathy case reports in Thailand using the health product vigilance center database","volume":"36","author":"Boonmuang","year":"2013","journal-title":"Drug Saf"},{"issue":"25","key":"10.1016\/j.jare.2017.04.008_b0585","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","article-title":"Colchicine myopathy and neuropathy","volume":"316","author":"Kuncl","year":"1987","journal-title":"N Engl J Med"},{"issue":"9627","key":"10.1016\/j.jare.2017.04.008_b0590","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0140-6736(08)60799-0","article-title":"Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial","volume":"371","author":"Janssens","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0595","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.annemergmed.2006.11.014","article-title":"Comparison of oral prednisolone\/paracetamol and oral indomethacin\/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial","volume":"49","author":"Man","year":"2007","journal-title":"Ann Emerg Med"},{"issue":"7","key":"10.1016\/j.jare.2017.04.008_b0600","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/M14-2070","article-title":"Oral prednisolone in the treatment of acute gout: a pragmatic, multicenter, double-blind, randomized trial","volume":"164","author":"Rainer","year":"2016","journal-title":"Ann Intern Med"},{"issue":"9646","key":"10.1016\/j.jare.2017.04.008_b0605","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(08)61548-2","article-title":"Should prednisolone be first-line therapy for acute gout?","volume":"372","author":"Richette","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0610","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jbspin.2012.09.009","article-title":"ACTH as first line treatment for acute gout in 181 hospitalized patients","volume":"80","author":"Daoussis","year":"2013","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0615","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0620","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1186\/ar4303","article-title":"Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases","volume":"15","author":"Ottaviani","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.jare.2017.04.008_b0625","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","article-title":"Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions","volume":"71","author":"Schlesinger","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0630","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/M16-0570","article-title":"Management of acute and recurrent gout: a clinical practice guideline from the american college of physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0635","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","article-title":"Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study","volume":"72","author":"Rees","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.jare.2017.04.008_b0640","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/ard.2009.124230","article-title":"Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial","volume":"69","author":"Dalbeth","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.jare.2017.04.008_b0645","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1093\/rheumatology\/keq256","article-title":"The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial","volume":"49","author":"Zhu","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.jare.2017.04.008_b0650","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.amjmed.2016.06.040","article-title":"Update on importance of diet in gout","volume":"129","author":"Beyl","year":"2016","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.jare.2017.04.008_b0655","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.2337\/diacare.28.12.2823","article-title":"Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome","volume":"28","author":"Azadbakht","year":"2005","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0660","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3109\/03009742.2012.679964","article-title":"Adherence to the Mediterranean diet and serum uric acid: the ATTICA study","volume":"41","author":"Kontogianni","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jare.2017.04.008_b0665","article-title":"Treat-to-target (T2T) recommendations for gout","author":"Kiltz","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.jare.2017.04.008_b0670","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/rheumatology\/keu157","article-title":"Prophylaxis for acute gout flares after initiation of urate-lowering therapy","volume":"53","author":"Latourte","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0675","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jare.2017.04.008_b0680","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrrheum.2014.124","article-title":"Improving cardiovascular and renal outcomes in gout: what should we target?","volume":"10","author":"Richette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"6158","key":"10.1016\/j.jare.2017.04.008_b0685","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bmj.1.6158.224","article-title":"Comparison of natriuretic, uricosuric, and antihypertensive properties of tienilic acid, bendrofluazide, and spironolactone","volume":"1","author":"Roberts","year":"1979","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.jare.2017.04.008_b0690","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jbspin.2011.05.010","article-title":"Treatment adherence in patients with gout","volume":"78","author":"Reach","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"8","key":"10.1016\/j.jare.2017.04.008_b0695","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM196902202800806","article-title":"Urinary xanthine stones\u2013a rare complications of allopurinol therapy","volume":"280","author":"Greene","year":"1969","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0700","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bcp.12799","article-title":"Predicting allopurinol response in patients with gout","volume":"81","author":"Wright","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jare.2017.04.008_b0705","article-title":"ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout","author":"Roberts","year":"2016","journal-title":"Pharmacogenomics J"},{"issue":"7","key":"10.1016\/j.jare.2017.04.008_b0710","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","article-title":"Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005","volume":"67","author":"Annemans","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"6 Suppl","key":"10.1016\/j.jare.2017.04.008_b0715","first-page":"627","article-title":"Treatment of gout with allopurinol. A study of 106 cases","volume":"25","author":"Delbarre","year":"1966","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"10.1016\/j.jare.2017.04.008_b0720","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jare.2017.04.008_b0725","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0730","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.semarthrit.2015.05.005","article-title":"An open-label, 6-month study of allopurinol safety in gout: The LASSO study","volume":"45","author":"Becker","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0735","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.2007.083071","article-title":"Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol","volume":"68","author":"Reinders","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0740","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0002-9343(89)90316-1","article-title":"Allopurinol hepatotoxicity","volume":"86","author":"Tam","year":"1989","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0745","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/art.1780150413","article-title":"Aplastic agranulocytosis after allopurinol therapy","volume":"15","author":"Greenberg","year":"1972","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0750","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-86-2-196","article-title":"Allopurinol-induced interstitial nephritis","volume":"86","author":"Gelbart","year":"1977","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0755","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000116934","article-title":"Regression of allopurinol-induced peripheral neuropathy after drug withdrawal","volume":"33","author":"Azulay","year":"1993","journal-title":"Eur Neurol"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0760","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP)\u2013a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0765","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0770","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0775","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/acr.21817","article-title":"Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort study","volume":"65","author":"Kim","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"10.1016\/j.jare.2017.04.008_b0780","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jamainternmed.2015.3536","article-title":"Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan","volume":"175","author":"Yang","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.jare.2017.04.008_b0785","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B\u22175801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.jare.2017.04.008_b0790","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jid.2016.02.808","article-title":"Impact of the HLA-B(\u2217)58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions","volume":"136","author":"Ng","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.jare.2017.04.008_b0795","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/art.34488","article-title":"Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol","volume":"64","author":"Stamp","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0800","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency","volume":"76","author":"Hande","year":"1984","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.jare.2017.04.008_b0805","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1136\/annrheumdis-2014-205577","article-title":"Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin","volume":"74","author":"Chung","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2017.04.008_b0810","doi-asserted-by":"crossref","first-page":"h4848","DOI":"10.1136\/bmj.h4848","article-title":"Use of HLA-B\u221758:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study","volume":"351","author":"Ko","year":"2015","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jare.2017.04.008_b0815","first-page":"1646","article-title":"Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout","volume":"33","author":"Dalbeth","year":"2006","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0820","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.30119","article-title":"Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment","volume":"63","author":"Stamp","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jare.2017.04.008_b0825","article-title":"Efficacy and safety of febuxostat in 73 gouty patients with stage 4\/5 chronic kidney disease: A retrospective study of 10 centers","author":"Juge","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0830","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/jcpt.12322","article-title":"Febuxostat-associated drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"40","author":"Chou","year":"2015","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"10.1016\/j.jare.2017.04.008_b0835","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jbspin.2015.07.011","article-title":"Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment","volume":"83","author":"Bardin","year":"2016","journal-title":"Joint Bone Spine"},{"issue":"7","key":"10.1016\/j.jare.2017.04.008_b0840","doi-asserted-by":"crossref","first-page":"e005354","DOI":"10.1136\/bmjopen-2014-005354","article-title":"Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia","volume":"4","author":"MacDonald","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jare.2017.04.008_b0845","first-page":"279","article-title":"Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis","volume":"64","author":"Gutman","year":"1951","journal-title":"Trans Assoc Am Physicians"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0850","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3899\/jrheum.121301","article-title":"Efficacy and tolerability of probenecid as urate-lowering therapy in gout; clinical experience in high-prevalence population","volume":"40","author":"Pui","year":"2013","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.jare.2017.04.008_b0855","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.57.9.545","article-title":"Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout","volume":"57","author":"Perez-Ruiz","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0860","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00124743-199904000-00003","article-title":"Treatment of chronic gout in patients with renal function impairment: an open, randomized, actively controlled study","volume":"5","author":"Perez-Ruiz","year":"1999","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jare.2017.04.008_b0865","article-title":"Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)","author":"Bardin","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jare.2017.04.008_b0870","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.39840","article-title":"Lesinurad combined with allopurinol: a randomized, double-blind, placebo-controlled study in gout patients with an inadequate response to standard-of-care allopurinol (a US-based study)","volume":"69","author":"Saag","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.jare.2017.04.008_b0875","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/ard.62.6.572","article-title":"Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and\/or losartan on uric acid metabolism","volume":"62","author":"Takahashi","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jare.2017.04.008_b0880","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ahj.2004.04.005","article-title":"Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia","volume":"148","author":"Milionis","year":"2004","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.jare.2017.04.008_b0885","first-page":"2093","article-title":"Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study","volume":"34","author":"Richette","year":"2007","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.jare.2017.04.008_b0890","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jama.2011.1169","article-title":"Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials","volume":"306","author":"Sundy","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jare.2017.04.008_b0895","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-016-4157-3","article-title":"Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition","volume":"60","author":"Vallon","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jare.2017.04.008_b0900","series-title":"Familiar medical quotations","author":"Strauss","year":"1968"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123217300450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123217300450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:44:22Z","timestamp":1761857062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123217300450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":180,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2090123217300450"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2017.04.008","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gout: An old disease in new perspective \u2013 A review","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2017.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Production and hosting by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}